Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 935

1.

Cystoid edema, neovascularization and inflammatory processes in the murine Norrin-deficient retina.

Beck SC, Karlstetter M, Garcia Garrido M, Feng Y, Dannhausen K, Mühlfriedel R, Sothilingam V, Seebauer B, Berger W, Hammes HP, Seeliger MW, Langmann T.

Sci Rep. 2018 Apr 13;8(1):5970. doi: 10.1038/s41598-018-24476-y.

2.

FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.

Schelch K, Wagner C, Hager S, Pirker C, Siess K, Lang E, Lin R, Kirschner MB, Mohr T, Brcic L, Marian B, Holzmann K, Grasl-Kraupp B, Krupitza G, Laszlo V, Klikovits T, Dome B, Hegedus B, Garay T, Reid G, van Zandwijk N, Klepetko W, Berger W, Grusch M, Hoda MA.

Carcinogenesis. 2018 Apr 5;39(4):534-545. doi: 10.1093/carcin/bgy018.

PMID:
29635378
3.

Human tripartite motif protein 52 is required for cell context-dependent proliferation.

Benke S, Agerer B, Haas L, Stöger M, Lercher A, Gabler L, Kiss I, Scinicariello S, Berger W, Bergthaler A, Obenauf AC, Versteeg GA.

Oncotarget. 2018 Feb 5;9(17):13565-13581. doi: 10.18632/oncotarget.24422. eCollection 2018 Mar 2.

4.

Design, synthesis, nuclear localization, and biological activity of a fluorescent duocarmycin analog, HxTfA.

Kiakos K, Englinger B, Yanow SK, Wernitznig D, Jakupec MA, Berger W, Keppler BK, Hartley JA, Lee M, Patil PC.

Bioorg Med Chem Lett. 2018 May 1;28(8):1342-1347. doi: 10.1016/j.bmcl.2018.03.016. Epub 2018 Mar 5.

PMID:
29548574
5.

Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS.

Klose MHM, Theiner S, Kornauth C, Meier-Menches SM, Heffeter P, Berger W, Koellensperger G, Keppler BK.

Metallomics. 2018 Mar 1;10(3):388-396. doi: 10.1039/c8mt00012c. Epub 2018 Mar 7.

PMID:
29513313
6.

Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.

Berger W, Sher E, Gawchik S, Fineman S.

Allergy Asthma Proc. 2018 Mar 1;39(2):110-116. doi: 10.2500/aap.2018.39.4116.

7.

Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men.

Valomon A, Holst SC, Borrello A, Weigend S, Müller T, Berger W, Sommerauer M, Baumann CR, Landolt HP.

Neuropsychopharmacology. 2018 Feb 5. doi: 10.1038/s41386-018-0018-8. [Epub ahead of print]

PMID:
29472644
8.

Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells.

Scharf I, Bierbaumer L, Huber H, Wittmann P, Haider C, Pirker C, Berger W, Mikulits W.

Oncol Lett. 2018 Feb;15(2):2441-2450. doi: 10.3892/ol.2017.7605. Epub 2017 Dec 13.

9.

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.

Mayr L, Pirker C, Lötsch D, Van Schoonhoven S, Windhager R, Englinger B, Berger W, Kubista B.

Oncotarget. 2017 Dec 9;8(69):114095-114108. doi: 10.18632/oncotarget.23125. eCollection 2017 Dec 26.

10.

Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.

Neubauer J, Lecca MR, Russo G, Bartsch C, Medeiros-Domingo A, Berger W, Haas C.

Int J Legal Med. 2018 Jan 19. doi: 10.1007/s00414-018-1775-y. [Epub ahead of print]

PMID:
29350269
11.

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Meltzer EO, Berger WE.

Allergy Asthma Proc. 2018 Jan 6;39(1):14-26. doi: 10.2500/aap.2018.39.4103.

PMID:
29279056
12.

Metal drugs become targeted.

Fuereder T, Berger W.

ESMO Open. 2017 Aug 17;2(3):e000239. doi: 10.1136/esmoopen-2017-000239. eCollection 2017. No abstract available.

13.

Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.

Brouwer TF, Vehmeijer JT, Kalkman DN, Berger WR, van den Born BH, Peters RJ, Knops RE.

Diabetes Care. 2017 Dec 6. pii: dc171722. doi: 10.2337/dc17-1722. [Epub ahead of print]

PMID:
29212825
14.

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.

Klikovits T, Stockhammer P, Laszlo V, Dong Y, Hoda MA, Ghanim B, Opitz I, Frauenfelder T, Nguyen-Kim TDL, Weder W, Berger W, Grusch M, Aigner C, Klepetko W, Dome B, Renyi-Vamos F, Oehler R, Hegedus B.

Sci Rep. 2017 Nov 28;7(1):16456. doi: 10.1038/s41598-017-16551-7.

15.

Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.

Meier-Menches SM, Gerner C, Berger W, Hartinger CG, Keppler BK.

Chem Soc Rev. 2018 Feb 5;47(3):909-928. doi: 10.1039/c7cs00332c. Review.

PMID:
29170783
16.

FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.

Ghassemi S, Vejdovszky K, Sahin E, Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J, Lackner A, Leopoldi A, Meindl D, Pirker C, Hegedus B, Marian B, Holzmann K, Grasl-Kraupp B, Heffeter P, Berger W, Grusch M.

Oncotarget. 2017 Sep 23;8(50):87750-87762. doi: 10.18632/oncotarget.21184. eCollection 2017 Oct 20.

17.

Can we spice up our Christmas dinner? : Busting the myth of the 'Chinese restaurant syndrome'.

van den Berg NWE, Neefs J, Berger WR, Baalman SWE, Meulendijks E, Kawasaki M, Kemper EM, Piersma FR, Veldkamp MW, Wesselink R, Krul SPJ, de Groot JR.

Neth Heart J. 2017 Dec;25(12):664-668. doi: 10.1007/s12471-017-1053-5.

18.

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.

Johnson TG, Schelch K, Cheng YY, Williams M, Sarun KH, Kirschner MB, Kao S, Linton A, Klebe S, McCaughan BC, Lin RCY, Pirker C, Berger W, Lasham A, van Zandwijk N, Reid G.

J Thorac Oncol. 2018 Feb;13(2):258-272. doi: 10.1016/j.jtho.2017.10.016. Epub 2017 Nov 4.

PMID:
29113949
19.

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Meltzer EO, Berger WE.

Allergy Asthma Proc. 2017 Nov 6. doi: 10.2500/aap.2017.38.1403. [Epub ahead of print]

PMID:
29108533
20.

Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls.

Thallinger C, Füreder T, Preusser M, Heller G, Müllauer L, Höller C, Prosch H, Frank N, Swierzewski R, Berger W, Jäger U, Zielinski C.

Wien Klin Wochenschr. 2018 Feb;130(3-4):85-91. doi: 10.1007/s00508-017-1285-9. Epub 2017 Nov 2. Review.

21.

Quality of life improves after thoracoscopic surgical ablation of advanced atrial fibrillation: Results of the Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery (AFACT) study.

Driessen AHG, Berger WR, Bierhuizen MFA, Piersma FR, van den Berg NWE, Neefs J, Krul SPJ, van Boven WP, de Groot JR.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):972-980. doi: 10.1016/j.jtcvs.2017.09.093. Epub 2017 Sep 27.

PMID:
29089093
22.

Abnormal creatine transport of mutations in monocarboxylate transporter 12 (MCT12) found in patients with age-related cataract can be partially rescued by exogenous chaperone CD147.

Stäubli A, Capatina N, Fuhrer Y, Munier FL, Labs S, Schorderet DF, Tiwari A, Verrey F, Heon E, Cheng CY, Wong TY, Berger W, Camargo SMR, Kloeckener-Gruissem B.

Hum Mol Genet. 2017 Nov 1;26(21):4203-4214. doi: 10.1093/hmg/ddx310.

PMID:
29088427
23.

Intrathoracic solitary fibrous tumor - an international multicenter study on clinical outcome and novel circulating biomarkers.

Ghanim B, Hess S, Bertoglio P, Celik A, Bas A, Oberndorfer F, Melfi F, Mussi A, Klepetko W, Pirker C, Berger W, Harmati I, Farkas A, Jan Ankersmit H, Dome B, Fillinger J, Aigner C, Hegedus B, Renyi-Vamos F, Lang G.

Sci Rep. 2017 Oct 2;7(1):12557. doi: 10.1038/s41598-017-12914-2.

24.

J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.

Kalkman DN, Brouwer TF, Vehmeijer JT, Berger WR, Knops RE, de Winter RJ, Peters RJ, van den Born BH.

Circulation. 2017 Dec 5;136(23):2220-2229. doi: 10.1161/CIRCULATIONAHA.117.030342. Epub 2017 Sep 22.

PMID:
28939617
25.

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.

Englinger B, Kallus S, Senkiv J, Heilos D, Gabler L, van Schoonhoven S, Terenzi A, Moser P, Pirker C, Timelthaler G, Jäger W, Kowol CR, Heffeter P, Grusch M, Berger W.

J Exp Clin Cancer Res. 2017 Sep 7;36(1):122. doi: 10.1186/s13046-017-0592-3.

26.

Synthesis and in vivo anticancer evaluation of poly(organo)phosphazene-based metallodrug conjugates.

Hackl CM, Schoenhacker-Alte B, Klose MHM, Henke H, Legina MS, Jakupec MA, Berger W, Keppler BK, Brüggemann O, Teasdale I, Heffeter P, Kandioller W.

Dalton Trans. 2017 Sep 28;46(36):12114-12124. doi: 10.1039/c7dt01767g. Epub 2017 Sep 1.

PMID:
28862707
27.

The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study.

Heilos D, Rodríguez-Carrasco Y, Englinger B, Timelthaler G, van Schoonhoven S, Sulyok M, Boecker S, Süssmuth RD, Heffeter P, Lemmens-Gruber R, Dornetshuber-Fleiss R, Berger W.

Toxins (Basel). 2017 Aug 24;9(9). pii: E258. doi: 10.3390/toxins9090258.

28.

Laser treatment of medical skin disease in women.

LaRosa C, Chiaravalloti A, Jinna S, Berger W, Finch J.

Int J Womens Dermatol. 2017 Jul 21;3(3):131-139. doi: 10.1016/j.ijwd.2017.05.002. eCollection 2017 Sep. Review.

29.

Unusual retinopathy in a child with severe combined immune deficiency.

Gerth-Kahlert C, Tiwari A, Hauri-Hohl MM, Hanson JVM, Bahr A, Palmowski-Wolfe A, Güngör T, Berger W.

Ophthalmic Genet. 2018 Jan-Feb;39(1):92-94. doi: 10.1080/13816810.2017.1350721. Epub 2017 Aug 16.

PMID:
28812413
30.

C2orf71 Mutations as a Frequent Cause of Autosomal-Recessive Retinitis Pigmentosa: Clinical Analysis and Presentation of 8 Novel Mutations.

Gerth-Kahlert C, Tiwari A, Hanson JVM, Batmanabane V, Traboulsi E, Pennesi ME, Al-Qahtani AA, Lam BL, Heckenlively J, Zweifel SA, Vincent A, Fierz F, Barthelmes D, Branham K, Khan N, Bahr A, Baehr L, Magyar I, Koller S, Azzarello-Burri S, Niedrist D, Heon E, Berger W.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3840-3850. doi: 10.1167/iovs.17-21597.

31.

MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.

van den Berg NWE, Kawasaki M, Berger WR, Neefs J, Meulendijks E, Tijsen AJ, de Groot JR.

Cardiovasc Drugs Ther. 2017 Jun;31(3):345-365. doi: 10.1007/s10557-017-6736-z. Review.

32.

Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis.

Schoenhacker-Alte B, Mohr T, Pirker C, Kryeziu K, Kuhn PS, Buck A, Hofmann T, Gerner C, Hermann G, Koellensperger G, Keppler BK, Berger W, Heffeter P.

Cancer Lett. 2017 Sep 28;404:79-88. doi: 10.1016/j.canlet.2017.07.009. Epub 2017 Jul 14.

PMID:
28716523
33.

Self-reported maximum walking distance in persons with MS may affect the EDSS.

Berger W, Payne MWC, Morrow SA.

J Neurol Sci. 2017 Aug 15;379:77-80. doi: 10.1016/j.jns.2017.05.035. Epub 2017 May 17.

PMID:
28716284
34.

Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."

Neefs J, van den Berg NWE, Limpens J, Berger WR, Boekholdt SM, Sanders P, de Groot JR.

Int J Cardiol. 2017 Sep 1;242:23. doi: 10.1016/j.ijcard.2017.03.007. No abstract available.

35.

Post-digestion stabilization of osmium enables quantification by ICP-MS in cell culture and tissue.

Klose MHM, Hejl M, Heffeter P, Jakupec MA, Meier-Menches SM, Berger W, Keppler BK.

Analyst. 2017 Jun 26;142(13):2327-2332. doi: 10.1039/c7an00350a.

PMID:
28585637
36.

Anion-Exchange Chromatography Coupled to High-Resolution Mass Spectrometry: A Powerful Tool for Merging Targeted and Non-targeted Metabolomics.

Schwaiger M, Rampler E, Hermann G, Miklos W, Berger W, Koellensperger G.

Anal Chem. 2017 Jul 18;89(14):7667-7674. doi: 10.1021/acs.analchem.7b01624. Epub 2017 Jun 27.

PMID:
28581703
37.

[11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice.

Traxl A, Beikbaghban T, Wanek T, Kryeziu K, Pirker C, Mairinger S, Stanek J, Filip T, Sauberer M, Kuntner C, Berger W, Langer O.

Nucl Med Biol. 2017 Sep;52:7-15. doi: 10.1016/j.nucmedbio.2017.05.007. Epub 2017 May 25.

PMID:
28575795
38.

Long-term consequences of developmental vascular defects on retinal vessel homeostasis and function in a mouse model of Norrie disease.

Beck SC, Feng Y, Sothilingam V, Garcia Garrido M, Tanimoto N, Acar N, Shan S, Seebauer B, Berger W, Hammes HP, Seeliger MW.

PLoS One. 2017 Jun 2;12(6):e0178753. doi: 10.1371/journal.pone.0178753. eCollection 2017.

39.

An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.

Meier SM, Kreutz D, Winter L, Klose MHM, Cseh K, Weiss T, Bileck A, Alte B, Mader JC, Jana S, Chatterjee A, Bhattacharyya A, Hejl M, Jakupec MA, Heffeter P, Berger W, Hartinger CG, Keppler BK, Wiche G, Gerner C.

Angew Chem Int Ed Engl. 2017 Jul 3;56(28):8267-8271. doi: 10.1002/anie.201702242. Epub 2017 May 26.

PMID:
28547791
40.

The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.

Berger WR, Jagu B, van den Berg NWE, Chan Pin Yin DRPP, van Straalen JP, de Boer OJ, Driessen AHG, Neefs J, Krul SPJ, van Boven WP, van der Wal AC, de Groot JR.

Europace. 2017 May 19. doi: 10.1093/europace/eux090. [Epub ahead of print]

PMID:
28525549
41.

An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.

Mayr J, Heffeter P, Groza D, Galvez L, Koellensperger G, Roller A, Alte B, Haider M, Berger W, Kowol CR, Keppler BK.

Chem Sci. 2017 Mar 1;8(3):2241-2250. doi: 10.1039/c6sc03862j. Epub 2016 Dec 15.

42.

Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.

Schnekenburger M, Goffin E, Lee JY, Jang JY, Mazumder A, Ji S, Rogister B, Bouider N, Lefranc F, Miklos W, Mathieu V, de Tullio P, Kim KW, Dicato M, Berger W, Han BW, Kiss R, Pirotte B, Diederich M.

J Med Chem. 2017 Jun 8;60(11):4714-4733. doi: 10.1021/acs.jmedchem.7b00533. Epub 2017 May 25.

PMID:
28475330
43.

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.

Nayak AS, Berger WE, LaForce CF, Urdaneta ER, Patel MK, Franklin KB, Wu MM.

Allergy Asthma Proc. 2017 May 1;38(3):222-230. doi: 10.2500/aap.2017.38.4050.

PMID:
28441993
44.

EGFR-targeting peptide-coupled platinum(IV) complexes.

Mayr J, Hager S, Koblmüller B, Klose MHM, Holste K, Fischer B, Pelivan K, Berger W, Heffeter P, Kowol CR, Keppler BK.

J Biol Inorg Chem. 2017 Jun;22(4):591-603. doi: 10.1007/s00775-017-1450-7. Epub 2017 Apr 12.

45.

Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.

Kubista B, Schoefl T, Mayr L, van Schoonhoven S, Heffeter P, Windhager R, Keppler BK, Berger W.

J Exp Clin Cancer Res. 2017 Apr 12;36(1):52. doi: 10.1186/s13046-017-0527-z.

46.

Functional Polymorphisms in Dopaminergic Genes Modulate Neurobehavioral and Neurophysiological Consequences of Sleep Deprivation.

Holst SC, Müller T, Valomon A, Seebauer B, Berger W, Landolt HP.

Sci Rep. 2017 Apr 10;7:45982. doi: 10.1038/srep45982.

47.

Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas.

Ingels A, Dinhof C, Garg AD, Maddau L, Masi M, Evidente A, Berger W, Dejaegher B, Mathieu V.

Cancer Chemother Pharmacol. 2017 May;79(5):971-983. doi: 10.1007/s00280-017-3293-x. Epub 2017 Apr 7.

PMID:
28389780
48.

Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.

Gojo J, Lötsch D, Spiegl-Kreinecker S, Pajtler KW, Neumayer K, Korbel P, Araki A, Brandstetter A, Mohr T, Hovestadt V, Chavez L, Kirchhofer D, Ricken G, Stefanits H, Korshunov A, Pfister SM, Dieckmann K, Azizi AA, Czech T, Filipits M, Kool M, Peyrl A, Slavc I, Berger W, Haberler C.

Neuro Oncol. 2017 Sep 1;19(9):1183-1194. doi: 10.1093/neuonc/nox027.

PMID:
28371821
49.

Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.

Driessen AH, Berger WR, Chan Pin Yin DR, Piersma FR, Neefs J, van den Berg NW, Krul SP, van Boven WP, de Groot JR.

J Am Coll Cardiol. 2017 Apr 4;69(13):1753-1754. doi: 10.1016/j.jacc.2017.01.035. No abstract available.

50.

Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis.

Erdem ZN, Schwarz S, Drev D, Heinzle C, Reti A, Heffeter P, Hudec X, Holzmann K, Grasl-Kraupp B, Berger W, Grusch M, Marian B.

Transl Oncol. 2017 Jun;10(3):332-339. doi: 10.1016/j.tranon.2017.02.004. Epub 2017 Mar 22.

Supplemental Content

Loading ...
Support Center